Table 4.

PROCAM risk crude (and standardized for age differences in brackets) in relation to BMI and waist circumference.

A. Male	≤ 94 cm	> 94 & ≤ 102 cm	> 102 cm	Total
< 25 kg/m2	3.61 (3.78) [n = 1,800; 23.41%]	5.84 (4.91) [n = 296; 3.85%]	6.77 (4.63*) [n = 30; 0.39%]	3.97 (4.0) [n = 2,126; 27.65%]
≥ 25& < 30 kg/m2	4.56 (4.64) [n = 1,026; 13.34%]	6.49 (5.49) [n = 1,564; 20.34%]	7.68 (5.83) [n = 974; 12.67%]	6.26 (5.35) [n = 3,564; 46.35%]
≥ 30 kg/m2	6.15 (5.9*) [n = 28; 0.36%]	6.07 (5.96) [n = 230; 2.99%]	7.35 (6.18) [n = 1,742; 22.65%]	7.19 (6.16) [n = 2,000; 26.01%]
Total	3.98 (4.12) [n = 2,854; 37.11%]	6.35 (5.47) [n = 2,090; 27.18%)	7.46 (6.05) [n = 2,746; 35.71%)	5.87 (5.22) [7,690; 100.00%]
B. Female	≤ 80 cm	> 80 & ≤ 88 cm	> 88 cm	Total
< 25 kg/m2	0.94 (1.08) [n = 2,438; 27.50%]	1.35 (1.35) [n = 889; 10.03%]	1.63 (1.62) [n = 223; 2.52%]	1.09 (1.19) [n = 3,550; 40.05%]
≥ 25& < 30 kg/m2	1.15 (1.23) [n = 360; 4.06%]	1.43 (1.46) [n = 1,008; 11.37%]	1.85 (1.75) [n = 1,566; 17.66%]	1.62 (1.59) [n = 2,934; 33.10%]
≥ 30 kg/m2	1.37 (1.29*) [n = 13; 0.15%]	1.53 (1.5) [n = 96; 1.08%]	1.86 (1.82) [n = 2,272; 25.63%]	1.85 (1.81) [n = 2,381; 26.86%]
Total	0.97 (1.1) [n = 2,811; 31.71%]	1.40 (1.41) [n = 1,993; 22.48%]	1.85 (1.78) [n = 4,061; 45.81%]	1.47 (1.5) [8865; 100.00%]

[number of patients per patient group with non-missing PROCAM; proportion of all patients with non-missing PROCAM].

PROCAM risk in relation to BMI and waist circumference [12]. N means number of patients with non-missing PROCAM in each cell; % of inner 9 cells adds up to 100%; the figure displayed is the risk for cardiovascular events for the next 10 years calculated with the PROCAM score (standardized for age). Crude/age-standardized mean are reported. * means that the total N in this cell is 30 or below and therefore the direct age standardization may have led to unreliable results.